Drug resistance and treatment failure in leishmaniasis: A 21st century challenge

• Alicia Ponte-Sucre ,

  * E-mail: barbara.papadopoulou@crchudequebec.ulaval.ca (BP); aiponte@gmail.com (APS)

  Affiliation Department of Physiological Sciences, Laboratory of Molecular Physiology, Institute of Experimental Medicine, Luis Razetti School of Medicine, Universidad Central de Venezuela, Caracas, Venezuela

  ⨯
• Francisco Gamarro,

  Affiliation Department of Biochemistry and Molecular Pharmacology, Instituto de Parasitología y Biomedicina López-Neyra, Spanish National Research Council (IPBLN-CSIC), Granada, Spain

  ⨯
• Jean-Claude Dujardin,

  Affiliation Molecular Parasitology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium

  ⨯
• Michael P. Barrett,

  Affiliation Wellcome Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Rogelio López-Vélez,

  Affiliation Department of Infectious Diseases, National Referral Unit for Tropical Diseases, Ramón y Cajal University Hospital, Madrid, Spain

  ⨯
• Raquel García-Hernández,

  Affiliation Department of Biochemistry and Molecular Pharmacology, Instituto de Parasitología y Biomedicina López-Neyra, Spanish National Research Council (IPBLN-CSIC), Granada, Spain

  ⨯
• Andrew W. Pountain,

  Affiliation Wellcome Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Roy Mwenechanya,

  Affiliation Department of Biomedical Sciences, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia

  ⨯
• Barbara Papadopoulou

  * E-mail: barbara.papadopoulou@crchudequebec.ulaval.ca (BP); aiponte@gmail.com (APS)

  Affiliation Research Center in Infectious Diseases, CHU de Quebec Research Center and Department of Microbiology-Infectious Disease and Immunology, University Laval, Quebec, Canada

  http://orcid.org/0000-0002-6697-9739

  ⨯